Login to Your Account


Shaking off the slump
Mustering hope in the obesity space – marked by drugs' generally disappointing sales despite a large and growing market – is tough, but Boston-based Zafgen Inc. recently drew investor enthusiasm and pulled off a $138 million public offering to advance what RBC Capital Markets analyst Simos Simeonidis called "a really impressive drug." more »

Our Habitat for All Things Science
Genome studies broaden and deepen as methods progress

TOKYO – In the nearly 12 years since the completion of the Human Genome Project, next-generation sequencing methods have made genome sequencing both faster and cheaper, leading to massive increases in the numbers of individuals who can be sequenced. Projects have gone from the Human Genome Project, to the 1,000 Genomes Project, to the announcement last week of a 100,000 Genomes Project that plans to start recruiting patients in February 2015. (See BioWorld Today, Dec. 23, 2014.)

READ MORE »